Status:
COMPLETED
Intravenous Dexamethasone and Dexmedetomidine on the Analgesic Efficacy of Erector Spinae Plane Block
Lead Sponsor:
Huazhong University of Science and Technology
Conditions:
Dexamethasone
Dexmedetomidine
Eligibility:
All Genders
18-65 years
Phase:
NA
Brief Summary
Patients having lumbar spinal fusion often complain about severe postoperative pain and postoperative rehabilitation process can be affected negatively. Postoperative pain that cannot be well controll...
Eligibility Criteria
Inclusion
- Age 18-65 yrs
- American Society of Anesthesiologists physical statusⅠ-Ⅲ
- Involvement of ≤3 spinal levels
- Undergo elective posterior lumbar interbody fusion
- Informed consent
Exclusion
- A known allergy to the drugs being used
- Pre-existing neuropsychiatric disorders or language barrier
- Analgesics intake, history of substance abuse
- Contraindications to peripheral nerve block
- Acute cerebrovascular disease
- Severe liver failure
- Uncontrolled low blood pressure
- Sinus bradycardia or atrioventricular block
Key Trial Info
Start Date :
March 1 2021
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 30 2021
Estimated Enrollment :
120 Patients enrolled
Trial Details
Trial ID
NCT04767256
Start Date
March 1 2021
End Date
December 30 2021
Last Update
March 29 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Union Hospital
Wuhan, Hubei, China